AstraZeneca C.E.O. to Step Down

David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.

Credit - http://feeds.nytimes.com/click.phdo?i=5febd808d6aceed9ca92a56ca860e2b4